Sevki Sahin

Prof. Dr. Sevki Sahin

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2008 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
FAFehime B. Aksungar
Fehime B. Aksungar
ATAynur E. Topkaya
Aynur E. Topkaya
ZYZeynep Yildiz
Zeynep Yildiz
SSSevki Sahin
Sevki Sahin
UTUlku Turk
Ulku Turk

1 August 2007 in Multiple Sclerosis Journal
Verified
Journal Article
Closed access
SSSevki Sahin
Sevki Sahin
FAF.B. Aksungar
F.B. Aksungar
ATA.E. Topkaya
A.E. Topkaya
ZYZ. Yildiz
Z. Yildiz
UBU.T. Boru
U.T. Boru
SKS. Karsidag
S. Karsidag


1 May 2020 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
DUDerya Uluduz
Derya Uluduz
IMIpek Midi
Ipek Midi
TDTaskin Duman
Taskin Duman
VYVildan Yayla
Vildan Yayla
AKAli Yavuz Karahan
Ali Yavuz Karahan
TGTaskin Gunes
Taskin Gunes

1 August 2017 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
FEFusun Er
Fusun Er
PIPınar Iscen
Pınar Iscen
SSSevki Sahin
Sevki Sahin
NÇNilgun Çinar
Nilgun Çinar
SKSibel Karsidag
Sibel Karsidag
DGDionysis Goularas
Dionysis Goularas

23 June 2017 in Neurology International
Verified
Journal Article
Open access
PDF file
SSSevki Sahin
Sevki Sahin
NCNilgun Cinar
Nilgun Cinar
SKSibel Karsidag
Sibel Karsidag
Guillain Barré syndrome (GBS) is a post-infectious acute autoimmune polyradiculopathy. Cerebrospinal fluid (CSF) total protein level and plasma neutrophil/ lymphocyte ratio (NLR) are related with autoimmune response. We aimed to reach a prognostic indicator for GBS by using electrophysiological findings, protein level of CSF, and plasma NLR based on Medical Research Council (MRC) sum score data. Cases who met diagnostic criteria of GBS and followed at least six months were enrolled in the study. Nerve conduction study (NCS) and lumbar puncture were performed one week after symptom onset. Routine CSF findings and complete blood count were recorded. Plasma NLR was calculated as the ratio of neutrophil cell count to lymphocyte cell count. All patients received intravenous immunoglobulin. MRC sum scores were calculated on administration time (1st) and six months later (2nd) for evaluation of recovery. Mean values of baseline CSF protein level, NCS parameters and NLR were compared with mean scores of MRC1st and MRC2nd. Increased CSF protein levels showed negative correlation with MRC2nd scores but no correlation with NCS. Increased NLR levels were positively correlated with age, MRC2nd scores and NCS. Facial diplegia was observed in 42% of patients. A positive correlation was found between high level of NLR and MRC1st, and there was no relationship with MRC2nd. Regression analyses showed that only CSF protein level was an independent factor on both MRC1st and MRC2nd. A positive association was found between baseline data included young age high plasma NLR, low level of CSF protein and good prognosis in our study. Also a positive correlation was found between high level of NLR and baseline disability in GBS cases with facial diplegia. Calculation of NLR is an easy and inexpensive method. On the other hand it may be influenced by age and immunotherapy. Our results showed that CSF protein level is still a liable parameter for prognosis. NLR could be a candidate prognostic marker of GBS cases. Further investigations including more cases are needed.